JUL 1, 2026 · JOURNAL ARTICLE
Iron deficiency in heart failure and cardiovascular diseases – from pathophysiology to modern strategies
Medical Journal of Cell Biology
High-quality evidence from multiple named RCTs (FAIR-HF, IRONMAN, HEARTFID, FAIR-HF2) demonstrating consistent clinical benefits of intravenous iron across objective endpoints (LVEF, functional capacity, hospitalization) and endorsed by major guideline bodies with strongest recommendation.
Reported
Iron deficiency prevalence in hea…40–80%
Iron deficiency prevalence in cor…around 60%
Iron deficiency prevalence in pul…40–60%